Overview

Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if a new add on (or adjunctive) therapy used in glaucoma surgery improves the success of needle bleb revisions.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Wills Eye
Treatments:
Bevacizumab
Pharmaceutical Solutions
Polystyrene sulfonic acid